- Home
- NVAX vs CCU Comparison
NVAX vs CCU Comparison
Compare NVAX & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- CCU
- Stock Information
- Founded
- NVAX 1987
- CCU 1850
- Country
- NVAX United States
- CCU Chile
- Employees
- NVAX N/A
- CCU N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- CCU Beverages (Production/Distribution)
- Sector
- NVAX Health Care
- CCU Consumer Staples
- Exchange
- NVAX Nasdaq
- CCU Nasdaq
- Market Cap
- NVAX 1.3B
- CCU 2.4B
- IPO Year
- NVAX 1995
- CCU 1992
- Fundamental
- Price
- NVAX $6.93
- CCU $12.69
- Analyst Decision
- NVAX Buy
- CCU Strong Sell
- Analyst Count
- NVAX 5
- CCU 2
- Target Price
- NVAX $16.60
- CCU $9.70
- AVG Volume (30 Days)
- NVAX 4.9M
- CCU 222.0K
- Earning Date
- NVAX 08-07-2025
- CCU 08-06-2025
- Dividend Yield
- NVAX N/A
- CCU 2.14%
- EPS Growth
- NVAX N/A
- CCU 67.38
- EPS
- NVAX 2.97
- CCU 0.47
- Revenue
- NVAX $1,254,962,000.00
- CCU $3,126,996,945.00
- Revenue This Year
- NVAX $56.85
- CCU $9.09
- Revenue Next Year
- NVAX N/A
- CCU $4.83
- P/E Ratio
- NVAX $2.30
- CCU $13.64
- Revenue Growth
- NVAX 25.92
- CCU 15.38
- 52 Week Low
- NVAX $5.01
- CCU $10.00
- 52 Week High
- NVAX $17.81
- CCU $15.75
- Technical
- Relative Strength Index (RSI)
- NVAX 51.12
- CCU 43.52
- Support Level
- NVAX $6.54
- CCU $12.82
- Resistance Level
- NVAX $7.20
- CCU $13.60
- Average True Range (ATR)
- NVAX 0.28
- CCU 0.33
- MACD
- NVAX 0.06
- CCU 0.06
- Stochastic Oscillator
- NVAX 66.36
- CCU 40.71
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.